- About Synapse
- How to Participate
- KAMJE Databases
- About Synapse
- How to Participate
- KAMJE Databases
| 1 |
Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities
Hasan Brau-Figueroa, Eder Arango-Bravo, Denisse Castro-Eguiluz, Tatiana Galicia-Carmona, Leopoldo Abraham Lugo-Alferez, Ivette Cruz-Bautista, Roberto Jiménez-Lima, Lucely Cetina-Pérez
Cancer Res Treat.2022;54(2):554-562. Published online 2021 August 10
DOI: http://dx.doi.org/10.4143/crt.2021.375
  |
|
| 2 |
Use of Gemcitabine Plus Carboplatin Is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4–5
Hyung-Don Kim, Hyeon-Su Im, Jwa Hoon Kim, Hyehyun Jeong, Shin Kyo Yoon, Inkeun Park, Jae Lyun Lee
Cancer Res Treat.2021;53(4):1166-1173. Published online 2021 March 4
DOI: http://dx.doi.org/10.4143/crt.2021.091
|
|
| 3 |
Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W. Ha
Cancer Res Treat.2021;53(4):1096-1103. Published online 2020 December 30
DOI: http://dx.doi.org/10.4143/crt.2020.928
|
|
| 4 |
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert
Cancer Res Treat.2021;53(2):457-470. Published online 2020 October 7
DOI: http://dx.doi.org/10.4143/crt.2020.585
|
|
| 5 |
Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to pancreatic cancer?
Dae Wook Hwang, Eun Shin, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon
Ann Hepatobiliary Pancreat Surg.2020;24(2):127-136. Published online 2020 May 31
DOI: http://dx.doi.org/10.14701/ahbps.2020.24.2.127
|
|
| 6 |
Antiviral Activity of Gemcitabine Against Echovirus 30 Infection in Vitro
Hwa-Jung Choi, Jae-Hyoung Song, Kyungah Yoon
J Bacteriol Virol.2019;49(4):203-211. Published online 2019 December 31
DOI: http://dx.doi.org/10.4167/jbv.2019.49.4.203
|
|
| 7 |
Clinical Outcomes of Second-Line Chemotherapy after Progression on Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo
Cancer Res Treat.2020;52(1):254-262. Published online 2019 July 9
DOI: http://dx.doi.org/10.4143/crt.2019.190
|
|
| 8 |
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo
Cancer Res Treat.2019;51(3):901-909. Published online 2018 October 4
DOI: http://dx.doi.org/10.4143/crt.2018.326
|
|
| 9 |
A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
Ye Won Jeon, Tae Hyun Kim, Hyun Jo Youn, Sehwan Han, Yongsik Jung, Geumhee Gwak, Young Sam Park, Jeong Soo Kim, Young Jin Suh
J Breast Cancer.2017;20(4):340-346. Published online 2017 December 19
DOI: http://dx.doi.org/10.4048/jbc.2017.20.4.340
|
|
| 10 |
Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study
Yunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kim
Cancer Res Treat.2018;50(1):175-182. Published online 2017 March 30
DOI: http://dx.doi.org/10.4143/crt.2016.535
|
|
| 11 |
Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study
Sang Myung Woo, Min Kyeong Kim, Jungnam Joo, Kyong-Ah Yoon, Boram Park, Sang-Jae Park, Sung-Sik Han, Ju Hee Lee, Eun Kyung Hong, Yun-Hee Kim, Hae Moon, Sun-Young Kong, Tae Hyun Kim, Woo Jin Lee
Cancer Res Treat.2017;49(4):1022-1032. Published online 2017 January 19
DOI: http://dx.doi.org/10.4143/crt.2016.495
|
|
| 12 |
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study
Keunchil Park, Eun Kyung Cho, Maximino Bello, Myung-Ju Ahn, Sumitra Thongprasert, Eun-Kee Song, Victoria Soldatenkova, Henrik Depenbrock, Tarun Puri, Mauro Orlando
Cancer Res Treat.2017;49(4):937-946. Published online 2017 January 6
DOI: http://dx.doi.org/10.4143/crt.2016.423
|
|
| 13 |
Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer
Hong-Beum Kim, Won Jin Cho, Nam Gyu Choi, Sung-Soo Kim, Jun Hee Park, Hee-Jeong Lee, Sang Gon Park
Ann Surg Treat Res.2017;92(1):15-22. Published online 2016 December 30
DOI: http://dx.doi.org/10.4174/astr.2017.92.1.15
|
|
| 14 |
Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model
Mi Hye Yu, Jae Young Lee, Hae Ri Kim, Bo Ram Kim, Eun-Joo Park, Hoe Suk Kim, Joon Koo Han, Byung Ihn Choi
Korean J Radiol.2016;17(5):779-788. Published online 2016 August 23
DOI: http://dx.doi.org/10.3348/kjr.2016.17.5.779
|
|
| 15 |
Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
Do Chang Moon, Hee Seung Lee, Yong Il Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Jae Bock Chung, Seungmin Bang
Yonsei Med J.2016;57(5):1124-1130. Published online 2016 June 30
DOI: http://dx.doi.org/10.3349/ymj.2016.57.5.1124
|
|
| 16 |
Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy
Inkeun Park, Seung Joon Choi, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yong Ju Shin, Dong Bok Shin
Cancer Res Treat.2016;48(4):1264-1273. Published online 2016 March 23
DOI: http://dx.doi.org/10.4143/crt.2015.250
|
|
| 17 |
A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer
Tak Yun, Heung Tae Kim, Ji-Youn Han, Sung Jin Yoon, Hyae Young Kim, Byung-Ho Nam, Jin Soo Lee
Cancer Res Treat.2016;48(2):465-472. Published online 2015 May 26
DOI: http://dx.doi.org/10.4143/crt.2015.061
|
|
| 18 |
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim
Cancer Res Treat.2015;47(3):343-361. Published online 2015 May 18
DOI: http://dx.doi.org/10.4143/crt.2014.308
|
|
| 19 |
Prognostic Factors in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine Chemotherapy: Clinical Characteristics of Long-term Survivors
Sung Gyu An, Dong Uk Kim, Geun Am Song, Ae Lee Jang
Korean J Gastroenterol.2014;64(6):356-363. Published online 2014 December 22
DOI: http://dx.doi.org/10.4166/kjg.2014.64.6.356
|
|
| 20 |
p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
Sung-Ung Moon, Jin Won Kim, Ji Hea Sung, Mi Hyun Kang, Se-Hyun Kim, Hyun Chang, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee
Cancer Res Treat.2015;47(3):501-508. Published online 2014 November 24
DOI: http://dx.doi.org/10.4143/crt.2014.054
|
|